Skip to main content
Erschienen in: American Journal of Clinical Dermatology 4/2018

01.08.2018 | Systematic Review

Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis

verfasst von: Khalaf Kridin, Arnon D. Cohen, Kyle T. Amber

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

There is little consensus regarding the prevalence and distribution of underlying systemic diseases among patients with pyoderma gangrenosum.

Objective

The objective of this study was to synthesize existing data on the prevalence of associated systemic diseases in patients with pyoderma gangrenosum.

Methods

We performed a systematic review and meta-analysis of observational studies in MEDLINE, EMBASE, and Scopus (1823–2017). The quality of evidence was assessed using a modified Newcastle–Ottawa Scale. A meta-analysis was performed using random-effects models to estimate pooled prevalence rates with 95% confidence intervals.

Results

Twenty-one eligible studies comprising 2611 patients with pyoderma gangrenosum were included in the quantitative synthesis. The overall random-effects pooled prevalence of associated systemic diseases was 56.8% (95% confidence interval 45.5–67.4). The leading underlying disease was inflammatory bowel disease (17.6%; 95% confidence interval 13.0–22.7), followed by arthritis (12.8%; 95% confidence interval 9.2–16.9), hematological malignancies (8.9%; 95% confidence interval 6.5–11.6), and solid malignancies (7.4%; 95% confidence interval 5.8–9.1). In 16.3% (95% confidence interval 7.7–27.1) of cases, the onset of pyoderma gangrenosum was attributed to the pathergy phenomenon.

Conclusions

More than half of patients with pyoderma gangrenosum present with a relevant underlying disease. Inflammatory bowel disease and arthritis are the most frequently associated diseases. Relative to the reported literature, the pooled prevalence of arthritis and hematological malignancies is lower, while the pooled prevalence of solid malignancies is higher. Owing to the high level of heterogeneity among most of the comparisons, results should be interpreted with caution.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45:202–10.CrossRefPubMed Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45:202–10.CrossRefPubMed
2.
Zurück zum Zitat Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017;176:1588–98.CrossRefPubMed Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017;176:1588–98.CrossRefPubMed
3.
Zurück zum Zitat Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol. 2014;178:48–56.CrossRefPubMedPubMedCentral Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol. 2014;178:48–56.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010;162:100–7.CrossRefPubMedPubMedCentral Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010;162:100–7.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73:691–8.CrossRefPubMed Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73:691–8.CrossRefPubMed
6.
Zurück zum Zitat Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol. 2016;175(5):882–91.CrossRefPubMed Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol. 2016;175(5):882–91.CrossRefPubMed
7.
9.
Zurück zum Zitat Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53:273–83.CrossRefPubMed Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53:273–83.CrossRefPubMed
10.
Zurück zum Zitat Hasselmann DO, Bens G, Tilgen W, Reichrath J. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges. 2007;5:560–4.CrossRefPubMed Hasselmann DO, Bens G, Tilgen W, Reichrath J. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges. 2007;5:560–4.CrossRefPubMed
11.
Zurück zum Zitat Al Ghazal P, Körber A, Klode J, Dissemond J. Investigation of new co-factors in 49 patients with pyoderma gangrenosum. Dtsch Dermatol Ges. 2012;10:251–7. Al Ghazal P, Körber A, Klode J, Dissemond J. Investigation of new co-factors in 49 patients with pyoderma gangrenosum. Dtsch Dermatol Ges. 2012;10:251–7.
12.
Zurück zum Zitat Al Ghazal P, Herberger K, Schaller J, Strölin A, Hoff N-P, Goerge T, et al. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis. 2013;8:136.CrossRefPubMedPubMedCentral Al Ghazal P, Herberger K, Schaller J, Strölin A, Hoff N-P, Goerge T, et al. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis. 2013;8:136.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857–72.CrossRefPubMed Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857–72.CrossRefPubMed
14.
Zurück zum Zitat Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRefPubMed Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRefPubMed
15.
Zurück zum Zitat Barbosa KGN, de Macedo Bernardino Í, d’Avila S, Ferreira EFE, Ferreira RC. Systematic review and meta-analysis to determine the proportion of maxillofacial trauma resulting from different etiologies among children and adolescents. Oral Maxillofac Surg. 2017;21:131–45.CrossRefPubMed Barbosa KGN, de Macedo Bernardino Í, d’Avila S, Ferreira EFE, Ferreira RC. Systematic review and meta-analysis to determine the proportion of maxillofacial trauma resulting from different etiologies among children and adolescents. Oral Maxillofac Surg. 2017;21:131–45.CrossRefPubMed
16.
Zurück zum Zitat Hermont AP, Oliveira PA, Martins CC, Paiva SM, Pordeus IA, Auad SM. Tooth erosion and eating disorders: a systematic review and meta-analysis. PLoS One. 2014;9:e111123.CrossRefPubMedPubMedCentral Hermont AP, Oliveira PA, Martins CC, Paiva SM, Pordeus IA, Auad SM. Tooth erosion and eating disorders: a systematic review and meta-analysis. PLoS One. 2014;9:e111123.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Mlika RB, Riahi I, Fenniche S, Mokni M, Raouf Dhaoui M, Dess N, et al. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol. 2002;41:65–8.CrossRefPubMed Mlika RB, Riahi I, Fenniche S, Mokni M, Raouf Dhaoui M, Dess N, et al. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol. 2002;41:65–8.CrossRefPubMed
18.
Zurück zum Zitat Cabalag MS, Wasiak J, Lim SW, Raiola FB. Inpatient management of pyoderma gangrenosum: treatments, outcomes, and clinical implications. Ann Plast Surg. 2015;74:354–60.CrossRefPubMed Cabalag MS, Wasiak J, Lim SW, Raiola FB. Inpatient management of pyoderma gangrenosum: treatments, outcomes, and clinical implications. Ann Plast Surg. 2015;74:354–60.CrossRefPubMed
19.
Zurück zum Zitat Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55:173–86.PubMed Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55:173–86.PubMed
20.
Zurück zum Zitat Suárez-Pérez JA, Herrera-Acosta E, López-Navarro N, Vilchez-Márquez F, Prieto JD, Bosch RJ, et al. Pyoderma gangrenosum: a report of 15 cases and review of the literature. Actas Dermosifiliogr. 2012;103:120–6.CrossRefPubMed Suárez-Pérez JA, Herrera-Acosta E, López-Navarro N, Vilchez-Márquez F, Prieto JD, Bosch RJ, et al. Pyoderma gangrenosum: a report of 15 cases and review of the literature. Actas Dermosifiliogr. 2012;103:120–6.CrossRefPubMed
21.
Zurück zum Zitat Marzano AV, Trevisan V, Lazzari R, Crosti C. Pyoderma gangrenosum: study of 21 patients and proposal of a “clinicotherapeutic” classification. J Dermatolog Treat. 2011;22:254–60.CrossRefPubMed Marzano AV, Trevisan V, Lazzari R, Crosti C. Pyoderma gangrenosum: study of 21 patients and proposal of a “clinicotherapeutic” classification. J Dermatolog Treat. 2011;22:254–60.CrossRefPubMed
22.
Zurück zum Zitat Pereira N, Brites MM, Goncalo M, Tellechea O, Figueiredo A. Pyoderma gangrenosum: a review of 24 cases observed over 10 years. Int J Dermatol. 2013;52:938–45.CrossRefPubMed Pereira N, Brites MM, Goncalo M, Tellechea O, Figueiredo A. Pyoderma gangrenosum: a review of 24 cases observed over 10 years. Int J Dermatol. 2013;52:938–45.CrossRefPubMed
23.
Zurück zum Zitat Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum: a comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37–46.CrossRef Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum: a comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37–46.CrossRef
24.
Zurück zum Zitat Inoue S, Furuta JI, Fujisawa Y, Onizawa S, Ito S, Sakiyama M, et al. Pyoderma gangrenosum and underlying diseases in Japanese patients: a regional long-term study. J Dermatol. 2017;44:1281–4.CrossRefPubMed Inoue S, Furuta JI, Fujisawa Y, Onizawa S, Ito S, Sakiyama M, et al. Pyoderma gangrenosum and underlying diseases in Japanese patients: a regional long-term study. J Dermatol. 2017;44:1281–4.CrossRefPubMed
25.
Zurück zum Zitat Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165:1244–50.CrossRefPubMed Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165:1244–50.CrossRefPubMed
26.
Zurück zum Zitat Jockenhöfer F, Herberger K, Schaller J, Hohaus KC, Stoffels-Weindorf M, Ghazal PA, et al. Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum. J Dtsch Dermatol Ges. 2016;14:1023–30.PubMed Jockenhöfer F, Herberger K, Schaller J, Hohaus KC, Stoffels-Weindorf M, Ghazal PA, et al. Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum. J Dtsch Dermatol Ges. 2016;14:1023–30.PubMed
27.
Zurück zum Zitat Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132:2166–70.CrossRefPubMed Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132:2166–70.CrossRefPubMed
28.
Zurück zum Zitat Jockenhofer F, Klode J, Kroger K, Roesch A, Al Ghazal P, Dissemond J. Patients with pyoderma gangrenosum: analyses of the German DRG data from 2012. Int Wound J. 2016;13:951–6.CrossRefPubMed Jockenhofer F, Klode J, Kroger K, Roesch A, Al Ghazal P, Dissemond J. Patients with pyoderma gangrenosum: analyses of the German DRG data from 2012. Int Wound J. 2016;13:951–6.CrossRefPubMed
29.
Zurück zum Zitat Vidal D, Puig L, Gilaberte M, Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat. 2004;15:146–52.CrossRefPubMed Vidal D, Puig L, Gilaberte M, Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat. 2004;15:146–52.CrossRefPubMed
30.
Zurück zum Zitat Von Den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997;137:1000–5.CrossRefPubMed Von Den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997;137:1000–5.CrossRefPubMed
31.
Zurück zum Zitat Ye MJ, Ye JM. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract. 2014;2014:461467.CrossRefPubMedPubMedCentral Ye MJ, Ye JM. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract. 2014;2014:461467.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Saracino A, Kelly R, Liew D, Chong A. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol. 2011;52:218–21.CrossRefPubMed Saracino A, Kelly R, Liew D, Chong A. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol. 2011;52:218–21.CrossRefPubMed
33.
Zurück zum Zitat Vacas AS, Torre AC, Bollea-Garlatti ML, Warley F, Galimberti RL. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. Int J Dermatol. 2017;56:386–91.CrossRefPubMed Vacas AS, Torre AC, Bollea-Garlatti ML, Warley F, Galimberti RL. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. Int J Dermatol. 2017;56:386–91.CrossRefPubMed
34.
Zurück zum Zitat Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33:787–802.CrossRefPubMed Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33:787–802.CrossRefPubMed
35.
Zurück zum Zitat Jackson JM, Callen JP. Pyoderma gangrenosum: an expert commentary. Expert Rev. Dermatol. 2006;1:391–400.CrossRef Jackson JM, Callen JP. Pyoderma gangrenosum: an expert commentary. Expert Rev. Dermatol. 2006;1:391–400.CrossRef
36.
Zurück zum Zitat Davis MDP, Moschella SL. Neutrophilic dermatoses. In: Bolognia J, Schaffer J, Cerroni L, editors. Dermatology. 4th ed. Philadelphia; Elsevier; 2017. p. 453–71. Davis MDP, Moschella SL. Neutrophilic dermatoses. In: Bolognia J, Schaffer J, Cerroni L, editors. Dermatology. 4th ed. Philadelphia; Elsevier; 2017. p. 453–71.
37.
Zurück zum Zitat Wolff K, Stingl G. Pyoderma gangrenosum. In: Freedberg I, Eisen A, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 5th ed. New York (NY): McGraw-Hill; 1999. p. 2207–13. Wolff K, Stingl G. Pyoderma gangrenosum. In: Freedberg I, Eisen A, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 5th ed. New York (NY): McGraw-Hill; 1999. p. 2207–13.
39.
Zurück zum Zitat Adisen E, Erduran F, Gurer MA. Pyoderma gangrenosum: a report of 27 patients. Int J Low Extrem Wounds. 2016;15:148–54.CrossRefPubMed Adisen E, Erduran F, Gurer MA. Pyoderma gangrenosum: a report of 27 patients. Int J Low Extrem Wounds. 2016;15:148–54.CrossRefPubMed
Metadaten
Titel
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis
verfasst von
Khalaf Kridin
Arnon D. Cohen
Kyle T. Amber
Publikationsdatum
01.08.2018
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2018
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-018-0356-7

Weitere Artikel der Ausgabe 4/2018

American Journal of Clinical Dermatology 4/2018 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.